glp 1 oral tablets Novo Nordisk's GLP-1 drug didn't work on Alzheimer's as hoped, but don't call it a failure New GLP-1 Pill Foundayo (Orforglipron)

Cagrilintide (AM833) Cagrilintide is a long-acting amylin analog designed for once-weekly (OW) SC administration (based on the structure of natural amylin), developed by Novo Nordisk [112]

Do not discontinue GLP-1 medications without medical guidance, as this may worsen blood glucose control or cause weight regain

They are taken as a small weekly injection you give yourself at home

Often, the "best" approach is combination therapy

Clinical studies show reductions in C-reactive protein, interleukin-6, and other inflammatory biomarkers

Until myBMI strengthens its communication, its reliability on paper will not fully match the confidence patients expect in practice